Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight?
- PMID: 33837295
- DOI: 10.1038/s41371-021-00537-0
Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight?
Comment on
-
The Cl-/HCO3- exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism.J Hum Hypertens. 2021 Oct;35(10):837-848. doi: 10.1038/s41371-020-00439-7. Epub 2020 Nov 10. J Hum Hypertens. 2021. PMID: 33173144
Similar articles
-
Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.Int J Urol. 2013 Jul;20(7):685-91. doi: 10.1111/iju.12029. Epub 2012 Nov 27. Int J Urol. 2013. PMID: 23190329
-
Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22. Hypertension. 2019. PMID: 31327258
-
Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy.Surgery. 2019 Sep;166(3):362-368. doi: 10.1016/j.surg.2019.05.001. Epub 2019 Jun 15. Surgery. 2019. PMID: 31208863
-
Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review.Horm Metab Res. 2012 Mar;44(3):221-7. doi: 10.1055/s-0031-1299681. Epub 2012 Jan 13. Horm Metab Res. 2012. PMID: 22395801 Review.
-
Surgery for primary hyperaldosteronism.Urol Clin North Am. 1989 Aug;16(3):535-45. Urol Clin North Am. 1989. PMID: 2665279 Review.
Cited by
-
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.Front Cardiovasc Med. 2022 Feb 2;8:798364. doi: 10.3389/fcvm.2021.798364. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35187110 Free PMC article. Review.
References
-
- Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3–17. - PubMed
-
- Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, et al. Primary aldosteronism: novel insights. Curr Hypertens Rev. 2020;16:19–23. - DOI
-
- Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889–916. - DOI
-
- Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008;371:1921–6. - DOI
-
- Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:42–50. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources